Skip to content

Japan REgistry for Adult subjeCTs of SMA

Japan REgistry for Adult subjeCTs of SMA - jREACT-SMA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042015
Enrollment
150
Registered
2020-10-07
Start date
2020-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Muscular Atrophy

Interventions

None listed

Sponsors

Nagoya University Graduate School of Medicine Biogen Japan Ltd. Chugai Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients with clinically diagnosed SMA, aged 18 years and older at the time of enrollment. 2)SMA patients with genetically confirmed loss of the SMN1 gene as well as retention of at least one copy of the SMN2 gene. 3)SMA patients who are available for follow-up visits. 4)SMA patients who can provide written consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1)SMA patients who have psychiatric disorder. 2)SMA patients who are judged as unsuitable for the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Collecting longitudinal data of Motor function and QOL/PRO

Countries

Japan

Contacts

Public ContactSatona Otake

Mebix, Inc. Research Promotion Group

sma_adult_registry@mebix.co.jp03-4362-4500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026